NO985972D0 - Indolinderivater anvendelige som 5-HT-2C reseptorantagonister - Google Patents
Indolinderivater anvendelige som 5-HT-2C reseptorantagonisterInfo
- Publication number
- NO985972D0 NO985972D0 NO985972A NO985972A NO985972D0 NO 985972 D0 NO985972 D0 NO 985972D0 NO 985972 A NO985972 A NO 985972A NO 985972 A NO985972 A NO 985972A NO 985972 D0 NO985972 D0 NO 985972D0
- Authority
- NO
- Norway
- Prior art keywords
- receptor antagonists
- derivatives useful
- indoline derivatives
- indoline
- useful
- Prior art date
Links
- 102000006902 5-HT2C Serotonin Receptor Human genes 0.000 title 1
- 108010072553 5-HT2C Serotonin Receptor Proteins 0.000 title 1
- 125000003387 indolinyl group Chemical class N1(CCC2=CC=CC=C12)* 0.000 title 1
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9612883.0A GB9612883D0 (en) | 1996-06-20 | 1996-06-20 | Novel compounds |
| PCT/EP1997/003156 WO1997048699A1 (en) | 1996-06-20 | 1997-06-16 | Indoline derivatives useful as 5-ht-2c receptor antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO985972L NO985972L (no) | 1998-12-18 |
| NO985972D0 true NO985972D0 (no) | 1998-12-18 |
Family
ID=10795575
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO985972A NO985972D0 (no) | 1996-06-20 | 1998-12-18 | Indolinderivater anvendelige som 5-HT-2C reseptorantagonister |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US6369060B1 (cs) |
| EP (1) | EP0912554B1 (cs) |
| JP (1) | JP2000512306A (cs) |
| KR (1) | KR20000022045A (cs) |
| CN (1) | CN1229408A (cs) |
| AP (2) | AP9801410A0 (cs) |
| AR (1) | AR008243A1 (cs) |
| AT (1) | ATE228514T1 (cs) |
| AU (1) | AU718597B2 (cs) |
| BG (1) | BG103089A (cs) |
| BR (1) | BR9709911A (cs) |
| CA (1) | CA2258240A1 (cs) |
| CO (1) | CO4890847A1 (cs) |
| CZ (1) | CZ420598A3 (cs) |
| DE (1) | DE69717449T2 (cs) |
| DZ (1) | DZ2250A1 (cs) |
| EA (1) | EA001780B1 (cs) |
| ES (1) | ES2187783T3 (cs) |
| GB (1) | GB9612883D0 (cs) |
| HU (1) | HUP9903439A3 (cs) |
| ID (1) | ID19433A (cs) |
| IL (1) | IL127417A0 (cs) |
| MA (1) | MA24214A1 (cs) |
| NO (1) | NO985972D0 (cs) |
| NZ (1) | NZ333229A (cs) |
| OA (1) | OA10944A (cs) |
| PE (1) | PE86698A1 (cs) |
| PL (1) | PL330796A1 (cs) |
| SK (1) | SK282706B6 (cs) |
| TR (1) | TR199802661T2 (cs) |
| TW (1) | TW382015B (cs) |
| WO (1) | WO1997048699A1 (cs) |
| ZA (1) | ZA975415B (cs) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3030899A (en) * | 1998-02-25 | 1999-09-15 | Smithkline Beecham Plc | Process(es) for the preparation of 6-trifluoromethyl-indoline derivatives |
| GB0019950D0 (en) * | 2000-08-12 | 2000-09-27 | Smithkline Beecham Plc | Compounds |
| BR0214529A (pt) | 2001-11-28 | 2006-05-30 | Upjohn Co | compostos terapêuticos |
| CA2475254A1 (en) * | 2002-03-04 | 2003-09-18 | Pharmacia & Upjohn Company | Pyridinyloxy derivatives as 5-ht receptor ligands |
| KR101062376B1 (ko) * | 2008-04-10 | 2011-09-06 | 한국화학연구원 | 신규 인돌 카르복실산 비스피리딜 카르복사마이드 유도체,이의 제조방법 및 이를 유효성분으로 함유하는 조성물 |
| JP2012515202A (ja) | 2009-01-16 | 2012-07-05 | マサチューセッツ インスティテュート オブ テクノロジー | 自閉症圏障害の診断および処置 |
| US20130267544A1 (en) | 2010-12-17 | 2013-10-10 | Peter Adamson | Use of LP-PLA2 Inhibitors in the Treatment and Prevention of Eye Diseases |
| WO2014046544A1 (en) | 2012-09-21 | 2014-03-27 | Aapa B.V. | Substituted 3-heteroaryloxy-3-(hetero)aryl-propylamines as serotonin transporter and serotonin ht2c receptor modulators |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1989001333A1 (en) * | 1987-08-07 | 1989-02-23 | The Australian National University | IMIDAZO[1,2-b]PYRIDAZINES |
| JPH08500580A (ja) | 1992-08-20 | 1996-01-23 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | ５ｈｔ▲下２ｃ▼および５ｈｔ▲下２ｂ▼拮抗薬用縮合インドール誘導体 |
| GB9313913D0 (en) * | 1993-07-06 | 1993-08-18 | Smithkline Beecham Plc | Novel compounds |
| PT808312E (pt) * | 1995-02-02 | 2001-03-30 | Smithkline Beecham Plc | Derivados de indolo antagonistas do receptor 5-ht |
| GB9607219D0 (en) * | 1996-04-04 | 1996-06-12 | Smithkline Beecham Plc | Novel compounds |
| GB9615767D0 (en) * | 1996-07-26 | 1996-09-04 | Smithkline Beecham Plc | Novel treatment |
-
1996
- 1996-06-20 GB GBGB9612883.0A patent/GB9612883D0/en active Pending
-
1997
- 1997-06-16 US US09/202,780 patent/US6369060B1/en not_active Expired - Fee Related
- 1997-06-16 AP APAP/P/1998/001410A patent/AP9801410A0/en unknown
- 1997-06-16 TR TR1998/02661T patent/TR199802661T2/xx unknown
- 1997-06-16 WO PCT/EP1997/003156 patent/WO1997048699A1/en not_active Ceased
- 1997-06-16 IL IL12741797A patent/IL127417A0/xx unknown
- 1997-06-16 BR BR9709911A patent/BR9709911A/pt unknown
- 1997-06-16 EA EA199900043A patent/EA001780B1/ru not_active IP Right Cessation
- 1997-06-16 AU AU32602/97A patent/AU718597B2/en not_active Ceased
- 1997-06-16 AT AT97928224T patent/ATE228514T1/de not_active IP Right Cessation
- 1997-06-16 ES ES97928224T patent/ES2187783T3/es not_active Expired - Lifetime
- 1997-06-16 CA CA002258240A patent/CA2258240A1/en not_active Abandoned
- 1997-06-16 EP EP97928224A patent/EP0912554B1/en not_active Expired - Lifetime
- 1997-06-16 SK SK1752-98A patent/SK282706B6/sk unknown
- 1997-06-16 KR KR1019980710443A patent/KR20000022045A/ko not_active Ceased
- 1997-06-16 CN CN97197311A patent/CN1229408A/zh active Pending
- 1997-06-16 CZ CZ984205A patent/CZ420598A3/cs unknown
- 1997-06-16 PL PL97330796A patent/PL330796A1/xx unknown
- 1997-06-16 HU HU9903439A patent/HUP9903439A3/hu unknown
- 1997-06-16 DE DE69717449T patent/DE69717449T2/de not_active Expired - Fee Related
- 1997-06-16 JP JP10502259A patent/JP2000512306A/ja active Pending
- 1997-06-16 NZ NZ333229A patent/NZ333229A/xx unknown
- 1997-06-18 AP APAP/P/1997/001037A patent/AP745A/en active
- 1997-06-18 DZ DZ970100A patent/DZ2250A1/fr active
- 1997-06-18 AR ARP970102673A patent/AR008243A1/es unknown
- 1997-06-18 PE PE1997000510A patent/PE86698A1/es not_active Application Discontinuation
- 1997-06-18 MA MA24666A patent/MA24214A1/fr unknown
- 1997-06-19 TW TW086108551A patent/TW382015B/zh not_active IP Right Cessation
- 1997-06-19 ZA ZA975415A patent/ZA975415B/xx unknown
- 1997-06-20 CO CO97034431A patent/CO4890847A1/es unknown
- 1997-06-20 ID IDP972126A patent/ID19433A/id unknown
-
1998
- 1998-12-18 NO NO985972A patent/NO985972D0/no unknown
- 1998-12-18 OA OA9800245A patent/OA10944A/en unknown
-
1999
- 1999-01-15 BG BG103089A patent/BG103089A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO985225L (no) | Indolderivater nyttige som endotelinreseptorantagonister | |
| FI973205A7 (fi) | Indolijohdannaisia 5-HT-reseptoriantagonisteina | |
| DK0630376T3 (da) | Kondenserede indolderivater som 5-HT4-receptorantagonister | |
| DK0856001T3 (da) | Pyrimidinderivater som 5-HT2C-receptor-antagonister | |
| NO965036D0 (no) | Kinolinderivater som techykinin NK3 reseptor-antagonister | |
| NO974043L (no) | Indolderivater som EAA-antagonister | |
| DK1068202T3 (da) | 1-(-heteroarylpropyl- eller -prop-2-enyl)-4benzylpipderidiner som NMDA-receptor-antagonister | |
| NO20002036D0 (no) | Cyklopentenderivater nyttig som antagonister for motilinreseptoren | |
| NO985970L (no) | Indolinderivater anvendelige som 5_HT-2C-reseptor-antagonister | |
| FI951798A0 (fi) | Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina | |
| NO985972D0 (no) | Indolinderivater anvendelige som 5-HT-2C reseptorantagonister | |
| AU3611099A (en) | Oxindole derivatives used as neurokinin receptor antagonists | |
| DK0885222T3 (da) | Heterocycliske ergolinderivater som 5HT1A-receptorligander | |
| NO963775D0 (no) | Indol-derivater som CCK-reseptorantagonister | |
| SI0912556T1 (en) | Indoline derivatives useful as 5-ht-2c receptor antagonists | |
| HK1019747A (en) | Indoline derivatives useful as 5-ht-2c receptor antagonists |